Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
Products
Automate
Trackers
Innovation Services
About Index
Index
By TNW
Log in
Register
Alimera Sciences
3127
Alimera Sciences
Health Care
Medical
Technology
Biotechnology
Pharmaceuticals
Biopharmaceutical company that researches, develops and commercializes prescription ophthalmic pharmaceuticals with a focus on the back of the eye, or retina.
Suggest edits
Founded
2003
Raised
$61.5M
Follow us
Companies in the same industry
TOT BIOPHARM
TCD Pharma
Aden Healthcare
Provia Laboratories
AFFiRiS AG
Mycodev Group
Hazel Technologies
Harlem Biospace
Shinom Cosmeceuticals
PeptiMimesis
Alexa global traffic share
Twitter followers
Overview
Funding
2
Add info
Latest funding
$26,500,000
Post-IPO equity - 2016
$35,000,000
Post-IPO debt - 2014
Team Size
50+
Employees
I work here
Location
United States
Headquarters
Explore United States
$26,500,000
Post-IPO equity
GlobeNewswire News Room
Alimera Sciences Announces Exercise of Underwriters’ Over-Allotment Option and Closing of $26.5 Million Offering of Comm...
